1. Home
  2. ROIV vs EVR Comparison

ROIV vs EVR Comparison

Compare ROIV & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.33

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$367.44

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
EVR
Founded
2014
1995
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
11.7B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
ROIV
EVR
Price
$21.33
$367.44
Analyst Decision
Strong Buy
Buy
Analyst Count
8
9
Target Price
$24.31
$332.22
AVG Volume (30 Days)
8.3M
302.4K
Earning Date
02-09-2026
02-04-2026
Dividend Yield
N/A
0.96%
EPS Growth
N/A
61.11
EPS
N/A
12.55
Revenue
$20,329,000.00
$3,542,875,000.00
Revenue This Year
N/A
$25.19
Revenue Next Year
$741.42
$16.43
P/E Ratio
N/A
$27.99
Revenue Growth
N/A
27.03
52 Week Low
$8.73
$148.63
52 Week High
$23.47
$364.42

Technical Indicators

Market Signals
Indicator
ROIV
EVR
Relative Strength Index (RSI) 48.66 69.62
Support Level $21.36 $338.95
Resistance Level $22.21 $353.30
Average True Range (ATR) 0.73 8.97
MACD -0.17 0.68
Stochastic Oscillator 19.30 82.40

Price Performance

Historical Comparison
ROIV
EVR

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

Share on Social Networks: